InvestorsHub Logo
Followers 800
Posts 50851
Boards Moderated 1
Alias Born 12/12/2004

Re: crudeoil24 post# 692

Thursday, 03/31/2022 1:51:43 PM

Thursday, March 31, 2022 1:51:43 PM

Post# of 813
ATHENA is a double-blind, placebo-controlled, Phase 3 trial of rucaparib in first-line ovarian cancer maintenance treatment. It has two parts which are statistically independent. The top-line results reported today are from the ATHENA-MONO part (rucaparib vs placebo) with results from the ATHENA-COMBO part (rucaparib+nivolumab vs rucaparib) now expected in Q1 2023 based on a slower than expected event count.


CLVS

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLVSQ News